The effects of azacitidine on the response and prognosis of myelodysplastic syndrome and acute myeloid leukemia involving a bone marrow erythroblast frequency of >50%

详细信息    查看全文

• 作者：Tomoyuki Uchida ; Masao Hagihara ; ^{hagihara@eijuhp.com} ; Jian Hua ; Morihiro Inoue
• 关键词：Myelodysplastic syndrome ; Acute erythroleukemia ; WHO ; Azacitidine
• 刊名：Leukemia Research
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：53
• 期：Complete
• 页码：35-38
• 全文大小：675 K
• 卷排序：53

文摘

HI could be achieved even if erythroblasts were dominant in BM. The overall survival was also not inferior in erythroblast-predominant group. Azacitidine could be an option irrespective of the numbers of erythroid cells in BM.